What Researchers Did
This retrospective study compared a novel hyperbaric oxygen therapy (HBOT) protocol to standard care in patients with acute central retinal artery occlusion (CRAO) presenting within 24 hours.
What They Found
At discharge, 76.5% of patients in the HBOT group showed a visual acuity (VA) improvement of at least 0.3 logMAR, compared to 40.6% in the non-HBOT group (p = 0.02). The mean logMAR VA at discharge was 1.4 ± 0.8 in the HBOT group versus 2.0 ± 0.8 in the non-HBOT group, with this difference sustained at one month.
What This Means for Canadian Patients
Canadian patients experiencing acute central retinal artery occlusion might see better visual outcomes if treated with this specific hyperbaric oxygen therapy protocol within 24 hours. This could potentially offer a new treatment option to preserve vision in a condition that often leads to severe visual loss.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study was limited by its small sample size and short-term outcome data, requiring further prospective validation.